Whitehawk Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 1.61141675
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

1.80 0.03 (1.69%)

52.76% Fall from 52W High

155.2K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

26.2 / 100

Technically Neutral

38.3 / 100

1Yr Price target upside is 11%

1 analysts

Whitehawk Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

52.76% Fall from 52W High

SWOT Analysis

Whitehawk Therapeutics Inc. Live Price Chart